Doak

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Direct oral anticoagulants; NOAK; Non-vitamin K-dependent anticoagulants

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Direct oral anticoagulants, DOAK for short, is the generic term for a group of anticoagulant drugs that act directly against certain coagulation factors and can be taken orally. Since these substances have only been on the market for a few years, the term "new oral anticoagulants" or "non-vitamin K-dependent anticoagulants" NOAKs is used alternatively.

Pharmacodynamics (Effect)This section has been translated automatically.

Anticoagulation by direct inhibition of factor Xa or thrombin. This results in a faster onset of action compared to vitamin K antagonists. There are currently 4 active ingredients available on the German market:

Details on the different active ingredients can be found under the respective keywords.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer